<DOC>
	<DOCNO>NCT00197912</DOCNO>
	<brief_summary>The aim study show vaccination autologous dendritic cell pulse peptide tumor lysate combination adjuvant cytokine Cyclophosphamide induce measurable immune response patient metastatic malignant melanoma , evaluate clinical effect ( objective response rate ) vaccination regime .</brief_summary>
	<brief_title>Dendritic Cell Based Therapy Malignant Melanoma</brief_title>
	<detailed_description>Eligible patient receive vaccination tumor antigen pulse autologous monocyte-derived mature dendritic cell fix interval . The dendritic cell generate leukapheresis product frozen antigen loading . HLA A2 positive patient treat PADRE oncopeptide pulsed DC ; p53 , survivin telomerase peptide . HLA A2 negative patient treat KLH tumorlysate pulse DC ; autologous allogeneic . Each patient give 6 immunization least 5x106 peptide/lysate pulse autologous DC . Vaccination 1-4 give weekly 4-6 2-week interval . Those patient exhibit stable disease , partial response complete response 6 injection give 4 vaccination 2-week interval . The vaccine apply intradermal injection near inguinal region . IL-2 2 MIU s.c. day 2-6 , Cyclophosphamide ( Sendoxan® , Baxter A/S ) 50 mg twice day bi-weekly 200 mg Celecoxib ( Celebra® , Pfizer ) daily use . Scans re-staging test perform schedule interval throughout study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Histologically proven progressive metastatic locally advanced melanoma No standard treatment indicated Age : &gt; 18 WHOPerformance Status 01 At least tone measurable tumor lesion accord RECIST criterion . Life expectancy 3 month Acceptable CBC blood chemistry result Written inform consent Patients history neoplastic disease le 5 year ago ( except treat carcinoma situ cervix basal/squamous cell carcinoma skin ) . Patients metastatic disease central nervous system ( CNS ) . Patients significant illness include severe allergy , asthma , angina pectoris congestive heart failure . Patients acute chronic infection include HIV , hepatitis tuberculosis . Patients pregnant . Patients receive antineoplastic therapy include chemotherapy immunotherapy le 4 week begin trial . Patients receive corticosteroid immunosuppressive agent . Baseline serum LDH great 2.5 time upper limit normal . Patients active autoimmune disease lupus erythematosus , rheumatoid arthritis thyroiditis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>dendritic cell</keyword>
	<keyword>cancer vaccine</keyword>
	<keyword>cyclophosphamide</keyword>
	<keyword>melanoma</keyword>
</DOC>